Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials

AST-120, an oral spherical activated carbon, may delay the need for kidney dialysis and improve uremia symptoms because it can adsorb acidic and basic organic compounds, especially small-molecule uremic toxins. However, previous studies produced no conclusive evidence regarding the benefits of AST-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Pei-Yu, Lee, Ya-Han, Kuo, Li-Na, Chen, Yen-Cheng, Chen, Chiehfeng, Kang, Yi-No, Chang, Elizabeth H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350440/
https://www.ncbi.nlm.nih.gov/pubmed/34381357
http://dx.doi.org/10.3389/fphar.2021.676345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350440/
https://www.ncbi.nlm.nih.gov/pubmed/34381357
http://dx.doi.org/10.3389/fphar.2021.676345

Ejemplares similares